<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/">

<channel>

<title>Healthline Today HealthCasts: Pharmacy</title>
<link>http://www.healthlinetoday.com/podcasts?cat=Pharmacy</link>
<itunes:subtitle>For Your Better Health</itunes:subtitle>
<itunes:summary></itunes:summary>
<description></description>
<language>en-us</language>
<copyright></copyright>
<itunes:owner>
   <itunes:name>Admin</itunes:name>
   <itunes:email>healthcasts@healthlinetoday.com</itunes:email>
</itunes:owner>
<managingEditor>healthcasts@healthlinetoday.com (Admin)</managingEditor>
<itunes:author>Admin</itunes:author>
<image>
   <url>http://www.healthlinetoday.com/podcasts/audio/rssimage.jpg</url>
   <title>Healthline Today HealthCasts</title>
   <link>http://www.healthlinetoday.com/podcasts</link>
</image>
<itunes:image href="http://www.healthlinetoday.com/podcasts/audio/itunescover.jpg" />
<pubDate>Thu, 09 Sep 2010 02:53:47 -0400</pubDate>
<lastBuildDate>Thu, 02 Jul 2009 16:52:00 -0400</lastBuildDate>
<generator>Loudblog</generator>

<itunes:explicit>no</itunes:explicit>

<itunes:category text="Health" />
<itunes:category text="Science &amp; Medicine" />
<itunes:category text="Health">
<itunes:category text="Fitness &amp; Nutrition" />
</itunes:category>
<itunes:category text="Sports &amp; Recreation" />
<category>Health</category>
<category>Science &amp; Medicine</category>
<category>Fitness &amp; Nutrition</category>
<category>Sports &amp; Recreation</category>


<item>
    <pubDate>Thu, 02 Jul 2009 16:52:00 -0400</pubDate>
    <title>CDC - A Cup of Health</title>
    <link>http://www.healthlinetoday.com/podcasts/index.php?id=2130</link>
    <guid>http://www.healthlinetoday.com/podcasts/index.php?id=2130</guid>
    <dc:creator>admin</dc:creator>
    <itunes:author>admin</itunes:author>
    <itunes:explicit>no</itunes:explicit>
    <comments>http://www.healthlinetoday.com/podcasts/index.php?id=2130#comments</comments>
    <itunes:keywords></itunes:keywords>
    <category>CDC</category>
    <category>Booster-shots</category>
    <category>influenza-B</category>
    <category>HIB-Vaccine</category>
    <category>vaccinations</category>
    <itunes:subtitle>Hib Booster is Back

Production of the Haemophilus influenzae type B, or Hib, vaccine has recently increased, following a temporary shortage brought on by a recall of certain lots of the vaccine in 2007. In this podcast, Dr. Andrew Kroger discusses the </itunes:subtitle>
    <itunes:summary>Hib Booster is Back

Production of the Haemophilus influenzae type B, or Hib, vaccine has recently increased, following a temporary shortage brought on by a recall of certain lots of the vaccine in 2007. In this podcast, Dr. Andrew Kroger discusses the reinstatement of the booster dose of the Hib vaccine.</itunes:summary>

<description>&lt;p&gt;&lt;a href="http://www.healthlinetoday.com/podcasts/audio/CDC_mmwr5_070209.mp3"&gt;File Download (3:58 min / 3 MB)&lt;/a&gt;&lt;/p&gt;</description>

    <enclosure url="http://www.healthlinetoday.com/podcasts/audio/CDC_mmwr5_070209.mp3" length="3145728" type="audio/mpeg" />
    <itunes:duration>00:03:58</itunes:duration>
</item>



<item>
    <pubDate>Thu, 02 Jul 2009 14:40:00 -0400</pubDate>
    <title>CDC - A Minute of Health</title>
    <link>http://www.healthlinetoday.com/podcasts/index.php?id=2116</link>
    <guid>http://www.healthlinetoday.com/podcasts/index.php?id=2116</guid>
    <dc:creator>admin</dc:creator>
    <itunes:author>admin</itunes:author>
    <itunes:explicit>no</itunes:explicit>
    <comments>http://www.healthlinetoday.com/podcasts/index.php?id=2116#comments</comments>
    <itunes:keywords></itunes:keywords>
    <category>CDC</category>
    <category>vaccinations</category>
    <category>Vaccines</category>
    <category>influenza</category>
    <category>booster-shot</category>
    <itunes:subtitle>Hib Booster is Back

Production of the Haemophilus influenzae type B, or Hib, vaccine has recently increased, following a temporary shortage brought on by a recall of certain lots of the vaccine in 2007. This podcast discusses the importance of children </itunes:subtitle>
    <itunes:summary>Hib Booster is Back

Production of the Haemophilus influenzae type B, or Hib, vaccine has recently increased, following a temporary shortage brought on by a recall of certain lots of the vaccine in 2007. This podcast discusses the importance of children who missed the booster shot receiving the booster at their next doctor&#039;s visit, and encourages parents to check with a healthcare provider to ensure their children are up-to-date on all vaccines.</itunes:summary>

<description>&lt;p&gt;&lt;a href="http://www.healthlinetoday.com/podcasts/audio/CDC_mmwr1_070209.mp3"&gt;File Download (0:59 min / 1 MB)&lt;/a&gt;&lt;/p&gt;</description>

    <enclosure url="http://www.healthlinetoday.com/podcasts/audio/CDC_mmwr1_070209.mp3" length="1048576" type="audio/mpeg" />
    <itunes:duration>00:00:59</itunes:duration>
</item>



<item>
    <pubDate>Mon, 04 May 2009 16:19:00 -0400</pubDate>
    <title>UMHS - Mi Research</title>
    <link>http://www.healthlinetoday.com/podcasts/index.php?id=2099</link>
    <guid>http://www.healthlinetoday.com/podcasts/index.php?id=2099</guid>
    <dc:creator>admin</dc:creator>
    <itunes:author>admin</itunes:author>
    <itunes:explicit>no</itunes:explicit>
    <comments>http://www.healthlinetoday.com/podcasts/index.php?id=2099#comments</comments>
    <itunes:keywords></itunes:keywords>
    <category>UMHS</category>
    <category>Mi-Research</category>
    <category>Medications</category>
    <category>pharmacy</category>
    <category>drug-interactions</category>
    <itunes:subtitle>Seniors should watch for drug interactions when taking multiple medications

A recent study found that more than 80 percent of adults age 57 and older take at least one prescription drug a day and that about half of them regularly mix drugs with </itunes:subtitle>
    <itunes:summary>Seniors should watch for drug interactions when taking multiple medications

A recent study found that more than 80 percent of adults age 57 and older take at least one prescription drug a day and that about half of them regularly mix drugs with over-the-counter medications and supplements.</itunes:summary>

<description>&lt;p&gt;&lt;a href="http://www.healthlinetoday.com/podcasts/audio/UMHS_druginteraction.mp3"&gt;File Download (3:19 min / 2 MB)&lt;/a&gt;&lt;/p&gt;</description>

    <enclosure url="http://www.healthlinetoday.com/podcasts/audio/UMHS_druginteraction.mp3" length="2097152" type="audio/mpeg" />
    <itunes:duration>00:03:19</itunes:duration>
</item>



<item>
    <pubDate>Thu, 23 Apr 2009 15:16:00 -0400</pubDate>
    <title>UMHS - Mi Health</title>
    <link>http://www.healthlinetoday.com/podcasts/index.php?id=2095</link>
    <guid>http://www.healthlinetoday.com/podcasts/index.php?id=2095</guid>
    <dc:creator>admin</dc:creator>
    <itunes:author>admin</itunes:author>
    <itunes:explicit>no</itunes:explicit>
    <comments>http://www.healthlinetoday.com/podcasts/index.php?id=2095#comments</comments>
    <itunes:keywords></itunes:keywords>
    <category>UMHS</category>
    <category>Childrens-Medications</category>
    <category>CAM</category>
    <category>Alternative-Medicines</category>
    <category>herbal-remedies</category>
    <itunes:subtitle>Alternative therapies can be safe, effective for children

Today, more children than ever are being treated with complementary and alternative therapies. Recent studies indicate that about 30 percent of healthy children and up to 50 percent of children </itunes:subtitle>
    <itunes:summary>Alternative therapies can be safe, effective for children

Today, more children than ever are being treated with complementary and alternative therapies. Recent studies indicate that about 30 percent of healthy children and up to 50 percent of children with chronic disease are using some kind of alternative therapy.</itunes:summary>

<description>&lt;p&gt;&lt;a href="http://www.healthlinetoday.com/podcasts/audio/UMHS_kidsaltmeds.mp3"&gt;File Download (2:19 min / 2 MB)&lt;/a&gt;&lt;/p&gt;</description>

    <enclosure url="http://www.healthlinetoday.com/podcasts/audio/UMHS_kidsaltmeds.mp3" length="2097152" type="audio/mpeg" />
    <itunes:duration>00:02:19</itunes:duration>
</item>



<item>
    <pubDate>Mon, 09 Mar 2009 15:11:00 -0400</pubDate>
    <title>FDA-SHOW84-SEG6.mpg</title>
    <link>http://www.healthlinetoday.com/podcasts/index.php?id=2083</link>
    <guid>http://www.healthlinetoday.com/podcasts/index.php?id=2083</guid>
    <dc:creator>admin</dc:creator>
    <itunes:author>admin</itunes:author>
    <itunes:explicit>no</itunes:explicit>
    <comments>http://www.healthlinetoday.com/podcasts/index.php?id=2083#comments</comments>
    <itunes:keywords></itunes:keywords>
    <category>FDA</category>
    <category>topical-anesthetics</category>
    <category>mammography</category>
    <category>drug-alert</category>
    <category>Breast-Cancer</category>
    <itunes:subtitle>Patients Are Asking: Caution Using Topical Anesthetics Prior to Mammography

FDA is alerting patients and healthcare professionals about the potential danger of using topical anesthetics to relieve pain before having mammography or other medical </itunes:subtitle>
    <itunes:summary>Patients Are Asking: Caution Using Topical Anesthetics Prior to Mammography

FDA is alerting patients and healthcare professionals about the potential danger of using topical anesthetics to relieve pain before having mammography or other medical procedures. The concern is that patients may apply these drugs improperly, which could cause excessive absorption of the drug. This could result in seizures, cardiac arrhythmias, respiratory failure, coma, and even death.</itunes:summary>

<description>&lt;p&gt;&lt;a href="http://www.healthlinetoday.com/podcasts/audio/FDA-SHOW84-SEG6.mpg"&gt;File Download (2:24 min / 14 MB)&lt;/a&gt;&lt;/p&gt;</description>

    <enclosure url="http://www.healthlinetoday.com/podcasts/audio/FDA-SHOW84-SEG6.mpg" length="14680064" type="application/octet-stream" />
    <itunes:duration>00:02:24</itunes:duration>
</item>



<item>
    <pubDate>Mon, 09 Mar 2009 14:53:00 -0400</pubDate>
    <title>FDA - Patient Safety News</title>
    <link>http://www.healthlinetoday.com/podcasts/index.php?id=2081</link>
    <guid>http://www.healthlinetoday.com/podcasts/index.php?id=2081</guid>
    <dc:creator>admin</dc:creator>
    <itunes:author>admin</itunes:author>
    <itunes:explicit>no</itunes:explicit>
    <comments>http://www.healthlinetoday.com/podcasts/index.php?id=2081#comments</comments>
    <itunes:keywords></itunes:keywords>
    <category>FDA</category>
    <category>prevent-medical-errors</category>
    <category>Alteplase</category>
    <category>ISMP</category>
    <itunes:subtitle>Preventing Medical Errors: Preventing Dosing Errors with Alteplase

In a recent report, the Institute for Safe Medication Practices warned about the possibility of prescribing and administering the wrong dose of alteplase when the indication for the drug </itunes:subtitle>
    <itunes:summary>Preventing Medical Errors: Preventing Dosing Errors with Alteplase

In a recent report, the Institute for Safe Medication Practices warned about the possibility of prescribing and administering the wrong dose of alteplase when the indication for the drug is not specified.</itunes:summary>

<description>&lt;p&gt;&lt;a href="http://www.healthlinetoday.com/podcasts/audio/FDA-SHOW84-SEG4.mpg"&gt;File Download (2:14 min / 13 MB)&lt;/a&gt;&lt;/p&gt;</description>

    <enclosure url="http://www.healthlinetoday.com/podcasts/audio/FDA-SHOW84-SEG4.mpg" length="13631488" type="application/octet-stream" />
    <itunes:duration>00:02:14</itunes:duration>
</item>



<item>
    <pubDate>Mon, 09 Mar 2009 14:44:00 -0400</pubDate>
    <title>FDA - Patient Safety News</title>
    <link>http://www.healthlinetoday.com/podcasts/index.php?id=2080</link>
    <guid>http://www.healthlinetoday.com/podcasts/index.php?id=2080</guid>
    <dc:creator>admin</dc:creator>
    <itunes:author>admin</itunes:author>
    <itunes:explicit>no</itunes:explicit>
    <comments>http://www.healthlinetoday.com/podcasts/index.php?id=2080#comments</comments>
    <itunes:keywords></itunes:keywords>
    <category>FDA</category>
    <category>Recalls</category>
    <category>Safety-Alerts</category>
    <category>Abacavir</category>
    <category>antiretroviral-drug</category>
    <category>HIV</category>
    <category>Aids</category>
    <category>immune-system</category>
    <itunes:subtitle>Recalls and Safety Alerts: Limitations of Skin Patch Testing for Diagnosing Hypersensitivity Reactions with Abacavir

FDA is cautioning healthcare professionals against using skin patch testing to immunologically confirm suspected cases of </itunes:subtitle>
    <itunes:summary>Recalls and Safety Alerts: Limitations of Skin Patch Testing for Diagnosing Hypersensitivity Reactions with Abacavir

FDA is cautioning healthcare professionals against using skin patch testing to immunologically confirm suspected cases of hypersensitivity reaction in patients treated with the antiretroviral drug abacavir. Abacavir is sold under the trade name Ziagen and is part of the combination products Epzicom and Trizivir.</itunes:summary>

<description>&lt;p&gt;&lt;a href="http://www.healthlinetoday.com/podcasts/audio/FDA-SHOW84-SEG3.mpg"&gt;File Download (2:14 min / 13 MB)&lt;/a&gt;&lt;/p&gt;</description>

    <enclosure url="http://www.healthlinetoday.com/podcasts/audio/FDA-SHOW84-SEG3.mpg" length="13631488" type="application/octet-stream" />
    <itunes:duration>00:02:14</itunes:duration>
</item>



<item>
    <pubDate>Mon, 09 Mar 2009 14:32:00 -0400</pubDate>
    <title>FDA - Patient Safety News</title>
    <link>http://www.healthlinetoday.com/podcasts/index.php?id=2079</link>
    <guid>http://www.healthlinetoday.com/podcasts/index.php?id=2079</guid>
    <dc:creator>admin</dc:creator>
    <itunes:author>admin</itunes:author>
    <itunes:explicit>no</itunes:explicit>
    <comments>http://www.healthlinetoday.com/podcasts/index.php?id=2079#comments</comments>
    <itunes:keywords></itunes:keywords>
    <category>FDA</category>
    <category>Recalls</category>
    <category>Safety-Alerts</category>
    <category>elderly</category>
    <category></category>
    <category>Innohep</category>
    <category>tinzaparin</category>
    <category>heparin</category>
    <category>deep-vein-thrombosis</category>
    <itunes:subtitle>Recalls and Safety Alerts: Higher Mortality for Certain Elderly Patients with Innohep

Celgene is alerting healthcare professionals of an increased mortality risk among certain elderly patients treated with Innohep (tinzaparin sodium injection). Innohep </itunes:subtitle>
    <itunes:summary>Recalls and Safety Alerts: Higher Mortality for Certain Elderly Patients with Innohep

Celgene is alerting healthcare professionals of an increased mortality risk among certain elderly patients treated with Innohep (tinzaparin sodium injection). Innohep is a low-molecular weight heparin that is used along with warfarin to treat acute symptomatic deep vein thrombosis with or without pulmonary embolism.</itunes:summary>

<description>&lt;p&gt;&lt;a href="http://www.healthlinetoday.com/podcasts/audio/FDA-SHOW84-SEG2.mpg"&gt;File Download (1:09 min / 6 MB)&lt;/a&gt;&lt;/p&gt;</description>

    <enclosure url="http://www.healthlinetoday.com/podcasts/audio/FDA-SHOW84-SEG2.mpg" length="6291456" type="application/octet-stream" />
    <itunes:duration>00:01:09</itunes:duration>
</item>



<item>
    <pubDate>Mon, 09 Mar 2009 14:20:00 -0400</pubDate>
    <title>FDA - Patient Safety News</title>
    <link>http://www.healthlinetoday.com/podcasts/index.php?id=2078</link>
    <guid>http://www.healthlinetoday.com/podcasts/index.php?id=2078</guid>
    <dc:creator>admin</dc:creator>
    <itunes:author>admin</itunes:author>
    <itunes:explicit>no</itunes:explicit>
    <comments>http://www.healthlinetoday.com/podcasts/index.php?id=2078#comments</comments>
    <itunes:keywords></itunes:keywords>
    <category>FDA</category>
    <category>Recalls</category>
    <category>Safety-Alert</category>
    <category>Fosphenytoin</category>
    <category>Phenytoin</category>
    <category>anti-epileptic-drug</category>
    <category>Seizure-Disorder</category>
    <itunes:subtitle>Recalls and Safety Alerts: Serious Skin Reactions in Asian Patients on Phenytoin and Fosphenytoin

FDA is investigating new preliminary data suggesting an increased risk of serious skin reactions from the anti-epileptic drugs phenytoin and fosphenytoin </itunes:subtitle>
    <itunes:summary>Recalls and Safety Alerts: Serious Skin Reactions in Asian Patients on Phenytoin and Fosphenytoin

FDA is investigating new preliminary data suggesting an increased risk of serious skin reactions from the anti-epileptic drugs phenytoin and fosphenytoin if they are taken by Asian patients who are positive for the human leukocyte antigen allele HLA-B*1502. These reactions include Stevens Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN). Phenytoin is marketed as Dilantin, Phenytek and generics. Fosphenytoin sodium is marketed as Cerebyx and generics.</itunes:summary>

<description>&lt;p&gt;&lt;a href="http://www.healthlinetoday.com/podcasts/audio/FDA-SHOW84-SEG1.mpg"&gt;File Download (2:36 min / 15 MB)&lt;/a&gt;&lt;/p&gt;</description>

    <enclosure url="http://www.healthlinetoday.com/podcasts/audio/FDA-SHOW84-SEG1.mpg" length="15728640" type="application/octet-stream" />
    <itunes:duration>00:02:36</itunes:duration>
</item>



<item>
    <pubDate>Fri, 06 Mar 2009 13:50:00 -0500</pubDate>
    <title>FDA - Drug Safety</title>
    <link>http://www.healthlinetoday.com/podcasts/index.php?id=2076</link>
    <guid>http://www.healthlinetoday.com/podcasts/index.php?id=2076</guid>
    <dc:creator>admin</dc:creator>
    <itunes:author>admin</itunes:author>
    <itunes:explicit>no</itunes:explicit>
    <comments>http://www.healthlinetoday.com/podcasts/index.php?id=2076#comments</comments>
    <itunes:keywords></itunes:keywords>
    <category>FDA</category>
    <category>Drug-Safety</category>
    <category>pharmacy</category>
    <category>Raptiva</category>
    <category>efalizumab</category>
    <category>alert</category>
    <category>Medicines</category>
    <category>plaque-psoriasis</category>
    <itunes:subtitle>Updated Safety Infromation about Raptiva (efalizumab)

Since the approval of Raptiva (efalizumab) in October 2003, the FDA has received reports of three confirmed cases and one possible case of progressive multifocal leukoencephalopathy </itunes:subtitle>
    <itunes:summary>Updated Safety Infromation about Raptiva (efalizumab)

Since the approval of Raptiva (efalizumab) in October 2003, the FDA has received reports of three confirmed cases and one possible case of progressive multifocal leukoencephalopathy leu·co·en·ceph·a·lop·a·thy  or PML in patients who were 47 to 73 years of age who were using Raptiva for the treatment of moderate to severe plaque psoriasis. Two of the patients with confirmed PML and one patient with possible PML died. All four patients were treated with Raptiva continuously for more than three years.  None of the patients were receiving other treatments that suppress the immune system while taking Raptiva.</itunes:summary>

<description>&lt;p&gt;&lt;a href="http://www.healthlinetoday.com/podcasts/audio/FDA_Raptiva_full.mp3"&gt;File Download (5:00 min / 5 MB)&lt;/a&gt;&lt;/p&gt;</description>

    <enclosure url="http://www.healthlinetoday.com/podcasts/audio/FDA_Raptiva_full.mp3" length="5242880" type="audio/mpeg" />
    <itunes:duration>00:05:00</itunes:duration>
</item>



<item>
    <pubDate>Thu, 05 Mar 2009 14:30:00 -0500</pubDate>
    <title>FDA Drug Safety</title>
    <link>http://www.healthlinetoday.com/podcasts/index.php?id=2094</link>
    <guid>http://www.healthlinetoday.com/podcasts/index.php?id=2094</guid>
    <dc:creator>admin</dc:creator>
    <itunes:author>admin</itunes:author>
    <itunes:explicit>no</itunes:explicit>
    <comments>http://www.healthlinetoday.com/podcasts/index.php?id=2094#comments</comments>
    <itunes:keywords></itunes:keywords>
    <category>FDA</category>
    <category>MRI</category>
    <category>Drug-Patches</category>
    <category>Pharmacy</category>
    <category>Drug-Safety</category>
    <category>Burns</category>
    <itunes:subtitle>Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings</itunes:subtitle>
    <itunes:summary>Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings</itunes:summary>

<description>&lt;p&gt;&lt;a href="http://www.healthlinetoday.com/podcasts/audio/FDA_Transdermal_patch.mp3"&gt;File Download (3:37 min / 3 MB)&lt;/a&gt;&lt;/p&gt;</description>

    <enclosure url="http://www.healthlinetoday.com/podcasts/audio/FDA_Transdermal_patch.mp3" length="3145728" type="audio/mpeg" />
    <itunes:duration>00:03:37</itunes:duration>
</item>



<item>
    <pubDate>Wed, 11 Feb 2009 16:49:00 -0500</pubDate>
    <title>FDA Patient Safety News</title>
    <link>http://www.healthlinetoday.com/podcasts/index.php?id=2050</link>
    <guid>http://www.healthlinetoday.com/podcasts/index.php?id=2050</guid>
    <dc:creator>admin</dc:creator>
    <itunes:author>admin</itunes:author>
    <itunes:explicit>no</itunes:explicit>
    <comments>http://www.healthlinetoday.com/podcasts/index.php?id=2050#comments</comments>
    <itunes:keywords></itunes:keywords>
    <category>FDA</category>
    <category>Cold-Medications</category>
    <category>nonprescription-cold-medicines</category>
    <category>Childrens-Medicines</category>
    <itunes:subtitle>Patients Are Asking: New Labels for Non-prescription Cough and Cold Medications

Most makers of nonprescription cough and cold medicines are voluntarily changing the labels on these products to say &quot;do not use&quot; for children under 4 years of </itunes:subtitle>
    <itunes:summary>Patients Are Asking: New Labels for Non-prescription Cough and Cold Medications

Most makers of nonprescription cough and cold medicines are voluntarily changing the labels on these products to say &quot;do not use&quot; for children under 4 years of age. New child resistant packaging and measuring devices are also being introduced.</itunes:summary>

<description>&lt;p&gt;&lt;a href="http://www.healthlinetoday.com/podcasts/audio/FDA-SHOW83-SEG7.mpg"&gt;File Download (2:21 min / 13 MB)&lt;/a&gt;&lt;/p&gt;</description>

    <enclosure url="http://www.healthlinetoday.com/podcasts/audio/FDA-SHOW83-SEG7.mpg" length="13631488" type="application/octet-stream" />
    <itunes:duration>00:02:21</itunes:duration>
</item>



<item>
    <pubDate>Wed, 11 Feb 2009 16:39:00 -0500</pubDate>
    <title>FDA Patient Safety News</title>
    <link>http://www.healthlinetoday.com/podcasts/index.php?id=2049</link>
    <guid>http://www.healthlinetoday.com/podcasts/index.php?id=2049</guid>
    <dc:creator>admin</dc:creator>
    <itunes:author>admin</itunes:author>
    <itunes:explicit>no</itunes:explicit>
    <comments>http://www.healthlinetoday.com/podcasts/index.php?id=2049#comments</comments>
    <itunes:keywords></itunes:keywords>
    <category>FDA</category>
    <category>ISMP</category>
    <category>Medical-Errors</category>
    <category>ketoconazole</category>
    <category>skin-disorders</category>
    <category>fluorouracil</category>
    <category>fungal-infections</category>
    <itunes:subtitle>Preventing Medical Errors: Drug Name Confusion Between Kuric and Carac

The Institute for Safe Medication Practices (ISMP) recently reported on the potential for mix-ups between two topical creams: Kuric (ketoconazole) and Carac (fluorouracil). Kuric is </itunes:subtitle>
    <itunes:summary>Preventing Medical Errors: Drug Name Confusion Between Kuric and Carac

The Institute for Safe Medication Practices (ISMP) recently reported on the potential for mix-ups between two topical creams: Kuric (ketoconazole) and Carac (fluorouracil). Kuric is used to treat fungal infections and seborrheic dermatitis. Carac is used to treat multiple actinic or solar keratoses of the face and anterior scalp.</itunes:summary>

<description>&lt;p&gt;&lt;a href="http://www.healthlinetoday.com/podcasts/audio/FDA-SHOW83-SEG6.mpg"&gt;File Download (1:26 min / 9 MB)&lt;/a&gt;&lt;/p&gt;</description>

    <enclosure url="http://www.healthlinetoday.com/podcasts/audio/FDA-SHOW83-SEG6.mpg" length="9437184" type="application/octet-stream" />
    <itunes:duration>00:01:26</itunes:duration>
</item>



<item>
    <pubDate>Wed, 11 Feb 2009 16:22:00 -0500</pubDate>
    <title>FDA Patient Safety News</title>
    <link>http://www.healthlinetoday.com/podcasts/index.php?id=2048</link>
    <guid>http://www.healthlinetoday.com/podcasts/index.php?id=2048</guid>
    <dc:creator>admin</dc:creator>
    <itunes:author>admin</itunes:author>
    <itunes:explicit>no</itunes:explicit>
    <comments>http://www.healthlinetoday.com/podcasts/index.php?id=2048#comments</comments>
    <itunes:keywords></itunes:keywords>
    <category>FDA</category>
    <category>Medical-Errors</category>
    <category>ISMP</category>
    <category>Purinethol</category>
    <category>mercaptopurine</category>
    <category>oncology</category>
    <category>antimetabolite</category>
    <category>Propylthiouracil</category>
    <category>anti-thyroid-agent</category>
    <category></category>
    <category></category>
    <itunes:subtitle>Preventing Medical Errors: More Mix-ups between Propylthiouracil and Purinethol

The Institute for Safe Medication Practices (ISMP) is warning about mix-ups between the trade name of one drug and the generic name of another. Purinethol® </itunes:subtitle>
    <itunes:summary>Preventing Medical Errors: More Mix-ups between Propylthiouracil and Purinethol

The Institute for Safe Medication Practices (ISMP) is warning about mix-ups between the trade name of one drug and the generic name of another. Purinethol® (mercaptopurine), is the trade name of a potent antimetabolite used in oncology. Propylthiouracil is an anti-thyroid agent that only comes in generic form.</itunes:summary>

<description>&lt;p&gt;&lt;a href="http://www.healthlinetoday.com/podcasts/audio/FDA-SHOW83-SEG5.mpg"&gt;File Download (3:47 min / 23 MB)&lt;/a&gt;&lt;/p&gt;</description>

    <enclosure url="http://www.healthlinetoday.com/podcasts/audio/FDA-SHOW83-SEG5.mpg" length="24117248" type="application/octet-stream" />
    <itunes:duration>00:03:47</itunes:duration>
</item>



<item>
    <pubDate>Wed, 11 Feb 2009 16:13:00 -0500</pubDate>
    <title>FDA Patient Safety News</title>
    <link>http://www.healthlinetoday.com/podcasts/index.php?id=2047</link>
    <guid>http://www.healthlinetoday.com/podcasts/index.php?id=2047</guid>
    <dc:creator>admin</dc:creator>
    <itunes:author>admin</itunes:author>
    <itunes:explicit>no</itunes:explicit>
    <comments>http://www.healthlinetoday.com/podcasts/index.php?id=2047#comments</comments>
    <itunes:keywords></itunes:keywords>
    <category>FDA</category>
    <category>Recalls</category>
    <category>Safety-Alerts</category>
    <category>Gynecologic-Surgery</category>
    <category>Surgical-Mesh</category>
    <category>womens-health</category>
    <category>Urinary-incontinence</category>
    <itunes:subtitle>Recalls and Safety Alerts: Serious Complications with Surgical Mesh for Gynecologic Surgery

The FDA is alerting healthcare professionals about rare but serious complications associated with the surgical mesh used to treat pelvic organ prolapse and </itunes:subtitle>
    <itunes:summary>Recalls and Safety Alerts: Serious Complications with Surgical Mesh for Gynecologic Surgery

The FDA is alerting healthcare professionals about rare but serious complications associated with the surgical mesh used to treat pelvic organ prolapse and stress urinary incontinence. The mesh is usually placed transvaginally using minimally invasive techniques.</itunes:summary>

<description>&lt;p&gt;&lt;a href="http://www.healthlinetoday.com/podcasts/audio/FDA-SHOW83-SEG4.mpg"&gt;File Download (1:53 min / 11 MB)&lt;/a&gt;&lt;/p&gt;</description>

    <enclosure url="http://www.healthlinetoday.com/podcasts/audio/FDA-SHOW83-SEG4.mpg" length="11534336" type="application/octet-stream" />
    <itunes:duration>00:01:53</itunes:duration>
</item>



</channel>

</rss>